Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entellus Medical Inc (ENTL) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entellus Medical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1374128.
Total stock buying since 2015: $18,021,602.
Total stock sales since 2015: $28,536,421.
Total stock option exercises since 2015: $84,664.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 6,655 | $159,947 | 0 | $0 |
| 2017 | 17,700 | $216,618 | 1,372,106 | $24,339,552 | 37,500 | $50,500 |
| 2016 | 0 | $0 | 148,287 | $2,873,010 | 0 | $0 |
| 2015 | 1,047,352 | $17,804,984 | 53,103 | $1,163,912 | 17,350 | $34,164 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-01 | 0 | $0 | 6,655 | $159,947 | 0 | $0 |
| 2017-12 | 0 | $0 | 101,319 | $2,416,458 | 0 | $0 |
| 2017-10 | 0 | $0 | 55,150 | $1,072,166 | 12,500 | $15,500 |
| 2017-09 | 0 | $0 | 27,000 | $474,500 | 25,000 | $35,000 |
| 2017-05 | 17,700 | $216,618 | 0 | $0 | 0 | $0 |
| 2017-01 | 0 | $0 | 1,188,637 | $20,376,428 | 0 | $0 |
| 2016-12 | 0 | $0 | 20,000 | $374,934 | 0 | $0 |
| 2016-11 | 0 | $0 | 20,000 | $371,500 | 0 | $0 |
| 2016-10 | 0 | $0 | 41,103 | $889,985 | 0 | $0 |
| 2016-09 | 0 | $0 | 29,328 | $545,294 | 0 | $0 |
| 2016-08 | 0 | $0 | 24,856 | $466,850 | 0 | $0 |
| 2016-07 | 0 | $0 | 3,000 | $54,447 | 0 | $0 |
| 2016-02 | 0 | $0 | 10,000 | $170,000 | 0 | $0 |
| 2015-10 | 0 | $0 | 0 | $0 | 16,100 | $19,964 |
| 2015-09 | 0 | $0 | 48,103 | $1,052,281 | 0 | $0 |
| 2015-08 | 0 | $0 | 5,000 | $111,631 | 0 | $0 |
| 2015-04 | 0 | $0 | 0 | $0 | 1,250 | $14,200 |
| 2015-02 | 1,047,352 | $17,804,984 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-08 | Williamson Thomas P. (VP, Commercial Operations) | Sale | 1,481 | 24.12 | 35,721 |
| 2018-01-05 | Williamson Thomas P. (VP, Commercial Operations) | Sale | 968 | 24.01 | 23,241 |
| 2018-01-05 | White Robert S. (President and CEO) | Sale | 3,471 | 24.01 | 83,338 |
| 2018-01-05 | Moen Brent (CFO and Secretary) | Sale | 735 | 24.01 | 17,647 |
| 2017-12-07 | Farley Brian E (Director) | Sale | 101,319 | 23.85 | 2,416,458 |
| 2017-10-20 | Mensink Kevin L (Vice President, Marketing) | Sale | 2,500 | 19.00 | 47,500 |
| 2017-10-20 | Mensink Kevin L (Vice President, Marketing) | Option Ex | 2,500 | 1.24 | 3,100 |
| 2017-10-16 | Mensink Kevin L (VP Marketing) | Sale | 10,000 | 18.29 | 182,900 |
| 2017-10-16 | Mensink Kevin L (VP Marketing) | Option Ex | 10,000 | 1.24 | 12,400 |
| 2017-10-09 | Peterson Karen E (VP, Regulatory and Quality) | Sale | 650 | 20.17 | 13,109 |
| 2017-10-04 | Petrick Timothy B (VP, Research & Development) | Sale | 2,000 | 20.01 | 40,026 |
| 2017-10-04 | Farley Brian E (Director) | Sale | 30,000 | 19.91 | 597,240 |
| 2017-10-03 | Farley Brian E (Director) | Sale | 6,028 | 19.16 | 115,526 |
| 2017-10-02 | Farley Brian E (Director) | Sale | 3,972 | 19.10 | 75,865 |
| 2017-09-22 | Petrick Timothy B (VP, Research & Development) | Sale | 2,000 | 18.00 | 36,000 |
| 2017-09-13 | Paidosh Stephen R (Vice President, Operations) | Sale | 25,000 | 17.54 | 438,500 |
| 2017-09-13 | Paidosh Stephen R (Vice President, Operations) | Option Ex | 25,000 | 1.40 | 35,000 |
| 2017-05-08 | White Robert S. (President and CEO) | Buy | 10,000 | 12.24 | 122,400 |
| 2017-05-08 | Moen Brent (CFO and Secretary) | Buy | 6,100 | 12.21 | 74,474 |
| 2017-05-08 | Baltzell Joshua J (Director) | Buy | 1,600 | 12.34 | 19,744 |
| 2017-01-31 | Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) | Sale | 581,541 | 17.00 | 9,886,197 |
| 2017-01-31 | International Life Sciences Fund Iii (lp1), L.p. (10% Owner) | Sale | 533,077 | 17.00 | 9,062,309 |
| 2017-01-13 | Peterson Karen E (VP, Regulatory & Quality) | Sale | 10,000 | 20.13 | 201,330 |
| 2017-01-13 | Farley Brian E (Director) | Sale | 14,019 | 20.14 | 282,314 |
| 2017-01-10 | Peterson Karen E (VP, Regulatory and Quality) | Sale | 4,840 | 19.10 | 92,444 |
| 2017-01-10 | Farley Brian E (Director) | Sale | 4,842 | 19.10 | 92,482 |
| 2017-01-09 | Peterson Karen E (VP, Regulatory and Quality) | Sale | 5,000 | 19.12 | 95,595 |
| 2017-01-09 | Farley Brian E (Director) | Sale | 5,000 | 19.12 | 95,595 |
| 2017-01-04 | Peterson Karen E (VP, Regulatory and Quality) | Sale | 160 | 19.10 | 3,056 |
| 2017-01-04 | Farley Brian E (Director) | Sale | 158 | 19.10 | 3,017 |
| 2017-01-03 | Peterson Karen E (VP, Regulatory and Quality) | Sale | 10,000 | 18.74 | 187,369 |
| 2017-01-03 | Farley Brian E (Director) | Sale | 20,000 | 18.74 | 374,720 |
| 2016-12-07 | Farley Brian E (Director) | Sale | 5,000 | 19.10 | 95,500 |
| 2016-12-06 | Farley Brian E (Director) | Sale | 4,348 | 18.70 | 81,307 |
| 2016-12-05 | Farley Brian E (Director) | Sale | 10,652 | 18.60 | 198,127 |
| 2016-11-23 | Farley Brian E (Director) | Sale | 5,000 | 19.00 | 95,000 |
| 2016-11-22 | Farley Brian E (Director) | Sale | 5,000 | 18.70 | 93,500 |
| 2016-11-18 | Farley Brian E (Director) | Sale | 5,000 | 18.30 | 91,500 |
| 2016-11-17 | Farley Brian E (Director) | Sale | 5,000 | 18.30 | 91,500 |
| 2016-10-13 | Boiano Margaret A (VP Healthcare Policy&Reimburse) | Sale | 11,103 | 20.01 | 222,215 |
| 2016-10-05 | Farley Brian E (Director) | Sale | 30,000 | 22.26 | 667,770 |
| 2016-09-08 | Surek James D (Vice President, Sales) | Sale | 10,000 | 18.71 | 187,150 |
| 2016-09-02 | Farley Brian E (Director) | Sale | 11,078 | 18.62 | 206,305 |
| 2016-09-01 | Mensink Kevin L (Vice President, Marketing) | Sale | 8,000 | 18.39 | 147,152 |
| 2016-09-01 | Farley Brian E (Director) | Sale | 250 | 18.75 | 4,687 |
| 2016-08-31 | Farley Brian E (Director) | Sale | 4,356 | 19.00 | 82,785 |
| 2016-08-30 | Farley Brian E (Director) | Sale | 12,400 | 19.46 | 241,254 |
| 2016-08-01 | Mensink Kevin L (Vice President, Marketing) | Sale | 8,100 | 17.63 | 142,811 |
| 2016-07-18 | Petrick Timothy B (VP, Research and Development) | Sale | 3,000 | 18.15 | 54,447 |
| 2016-02-04 | Peterson Karen E (SEE REMARKS) | Sale | 10,000 | 17.00 | 170,000 |
| 2015-10-29 | Mensink Kevin L (VICE PRESIDENT, MARKETING) | Option Ex | 16,100 | 1.24 | 19,964 |
| 2015-09-17 | Farley Brian E (EXECUTIVE CHAIRMAN) | Sale | 4,566 | 22.00 | 100,452 |
| 2015-09-16 | Farley Brian E (EXECUTIVE CHAIRMAN) | Sale | 918 | 22.01 | 20,207 |
| 2015-09-15 | Farley Brian E (EXECUTIVE CHAIRMAN) | Sale | 6,432 | 22.26 | 143,157 |
| 2015-09-14 | Farley Brian E (EXECUTIVE CHAIRMAN) | Sale | 21,187 | 22.15 | 469,355 |
| 2015-09-02 | Surek James D (VICE PRESIDENT, SALES) | Sale | 15,000 | 21.27 | 319,110 |
| 2015-08-31 | Surek James D (VICE PRESIDENT, SALES) | Sale | 791 | 22.20 | 17,560 |
| 2015-08-28 | Surek James D (VICE PRESIDENT, SALES) | Sale | 4,209 | 22.35 | 94,071 |
| 2015-04-21 | Baltzell Joshua J (Director) | Option Ex | 1,250 | 11.36 | 14,200 |
| 2015-02-03 | White Robert S. (PRESIDENT & COO) | Buy | 5,882 | 17.00 | 99,994 |
| 2015-02-03 | Mccormick Shawn (Director) | Buy | 2,941 | 17.00 | 49,997 |
| 2015-02-03 | Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) | Buy | 352,941 | 17.00 | 5,999,997 |
| 2015-02-03 | Sv Life Sciences Fund Iv, L.p. (10% Owner) | Buy | 317,647 | 17.00 | 5,399,999 |
| 2015-02-03 | Split Rock Partners Management Llc (10% Owner) | Buy | 352,941 | 17.00 | 5,999,997 |
| 2015-02-03 | Neels Guido J (Director) | Buy | 15,000 | 17.00 | 255,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENTL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entellus Medical Inc (symbol ENTL, CIK number 1374128) see the Securities and Exchange Commission (SEC) website.